Clinical Trials · NCT06745128
Tirzepatide for Obesity and Meth Use Disorder
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University of Texas Southwestern Medical Center
- Enrollment
- 35
- Start date
- Feb 2025
- Locations
- 1 site, United States
- Primary endpoint
- Effect of tirzepatide on self-reported use of methamphetamine